Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Prelude Therapeutics Inc (PRLD)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 43,700,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Prelude Therapeutics is a clinical-stage oncology company built on a foundation of drug discovery to deliver precision cancer medicines to underserved patients. Co.'s primary candidates are designed to be oral, potent and selective inhibitors of protein arginine methyltransferase 5 (PRMT5). PRT811, Co.'s second clinical candidate, is a PRMT5 inhibitor that it has optimized for high brain exposure. PRT1419, Co.'s third clinical candidate, is designed to be a potent and selective inhibitor of the anti-apoptotic protein, MCL1. PRT2527, Co.'s fourth clinical candidate, is designed to be a potent and selective Cyclin-dependent kinase 9 inhibitor.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,760,286 1,799,474
Total Buy Value $0 $0 $10,116,973 $10,305,319
Total People Bought 0 0 5 5
Total Buy Transactions 0 0 7 10
Total Shares Sold 0 0 0 13,280
Total Sell Value $0 $0 $0 $81,274
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 100
  Page 3 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Piper Brian Chief Financial Officer   •       –      –    2021-05-25 4 OE $1.89 $15,749 D/D 8,333 8,333     -
   Scherle Peggy Chief Scientific Officer   •       –      –    2021-05-07 4 AS $40.30 $408,192 D/D (10,000) 172,920     -
   Scherle Peggy Chief Scientific Officer   •       –      –    2021-05-07 4 OE $1.43 $14,300 D/D 10,000 182,920     -
   Mauro David J Chief Medical Officer   •       –      –    2021-05-05 4 AS $39.36 $602,092 D/D (15,000) 0     -
   Mauro David J Chief Medical Officer   •       –      –    2021-05-05 4 OE $1.89 $28,350 D/D 15,000 15,000     -
   Morosini Deborah EVP, Chief of Clinical Affairs   •       –      –    2021-04-29 4 AS $40.29 $129,853 D/D (3,223) 444     -
   Morosini Deborah EVP, Chief of Clinical Affairs   •       –      –    2021-04-29 4 OE $1.89 $6,091 D/D 3,223 3,667     -
   Pierce Christopher EVP and Chief of Business Oper   •       –      –    2021-04-29 4 AS $40.29 $132,765 D/D (3,295) 3,750     -
   Pierce Christopher EVP and Chief of Business Oper   •       –      –    2021-04-29 4 OE $1.89 $6,228 D/D 3,295 7,045     -
   Mauro David J Chief Medical Officer   •       –      –    2021-04-27 4 AS $34.66 $884,848 D/D (25,000) 0     -
   Mauro David J Chief Medical Officer   •       –      –    2021-04-27 4 OE $1.89 $47,250 D/D 25,000 25,000     -
   Mauro David J Chief Medical Officer   •       –      –    2021-04-19 4 AS $30.82 $772,349 D/D (25,000) 0     -
   Mauro David J Chief Medical Officer   •       –      –    2021-04-19 4 OE $1.89 $47,250 D/D 25,000 25,000     -
   Pierce Christopher EVP and Chief of Business Oper   •       –      –    2021-04-08 4 AS $40.00 $8,000 D/D (200) 3,750     -
   Pierce Christopher EVP and Chief of Business Oper   •       –      –    2021-04-08 4 A $1.89 $378 D/D 200 3,950     -
   Scherle Peggy Chief Scientific Officer   •       –      –    2021-04-08 4 AS $36.97 $177,504 D/D (4,630) 172,920     -
   Scherle Peggy Chief Scientific Officer   •       –      –    2021-04-08 4 A $1.43 $6,621 D/D 4,630 177,550     -
   Mauro David J Chief Medical Officer   •       –      –    2021-04-08 4 AS $37.04 $368,852 D/D (9,617) 0     -
   Mauro David J Chief Medical Officer   •       –      –    2021-04-08 4 OE $1.89 $18,176 D/D 9,617 9,617     -
   Morosini Deborah EVP, Chief of Clinical Affairs   •       –      –    2021-04-08 4 AS $40.00 $4,000 D/D (100) 444     -
   Morosini Deborah EVP, Chief of Clinical Affairs   •       –      –    2021-04-08 4 OE $1.89 $189 D/D 100 544     -
   Pierce Christopher EVP and Chief of Business Oper   •       –      –    2021-04-07 4 AS $40.08 $33,188 D/D (828) 3,750     -
   Pierce Christopher EVP and Chief of Business Oper   •       –      –    2021-04-07 4 A $1.89 $1,565 D/D 828 4,578     -
   Mauro David J Chief Medical Officer   •       –      –    2021-04-07 4 AS $39.03 $605,023 D/D (15,383) 0     -
   Mauro David J Chief Medical Officer   •       –      –    2021-04-07 4 OE $1.89 $29,074 D/D 15,383 15,383     -
  100 Records found
  1  2  3  4   
  Page 3 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us